🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
This study will evaluate the safety of PD-1 knockout engineered T cells in ...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2016-08-26
Trial ID
NCT02793856
Treatments Being Tested
The immune system has offensive and defensive capacities. In bone marrow tr...
Status
Terminated
Location
Katholieke Universiteit Leuven
Start Date
2013-07
Trial ID
NCT01903473
Treatments Being Tested
Regulatory CD4+CD25+ T cells (Treg) derived from the thymus and/or peripher...
Status
Completed
Location
Northwestern University Comprehensive Transplant Center
Start Date
2014-04
Trial ID
NCT02145325
Treatments Being Tested
The investigational therapy under study in this trial, regulatory T cells (...
Status
Completed
Location
University of California, San Francisco Medical Center
Start Date
2010-11
Trial ID
NCT01210664
Treatments Being Tested
The main purpose of the study is to check: * Can therapy with a preparatio...
Status
Recruiting
Location
Uniwersytecki Dzieciecy Szpital Kliniczny Im. L. Zamenhofa W Bialymstoku
Start Date
2025-03-12
Trial ID
NCT06688331
Investigators aim to develop an effective and safe treatment of autoimmune ...
Status
Unknown
Location
Ain shams university, faculty of medicine
Start Date
2022-12
Trial ID
NCT05566977
Treatments Being Tested
The goal of this multi-national, multi-center, open-label, randomized Phase...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-06-13
Trial ID
NCT06552169
Treatments Being Tested
The purpose of this study is: * To see if polyTregs can reduce inflammatio...
Status
Completed
Location
University of Alabama, Birmingham
Start Date
2016-09-20
Trial ID
NCT02711826
This Phase I study will determine the safety and optimal dose of expanded a...
Status
Unknown
Location
King's College Hospital
Start Date
2022-07-14
Trial ID
NCT05386264
Treatments Being Tested